193 related articles for article (PubMed ID: 26146615)
1. Anatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future Implications.
Chang J; Schomer D; Dragovich T
Biomed Res Int; 2015; 2015():269641. PubMed ID: 26146615
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
Schima W; Függer R; Schober E; Oettl C; Wamser P; Grabenwöger F; Ryan JM; Novacek G
AJR Am J Roentgenol; 2002 Sep; 179(3):717-24. PubMed ID: 12185052
[TBL] [Abstract][Full Text] [Related]
3. Local extension of pancreatic carcinoma: assessment with thin-section helical CT versus with breath-hold fast MR imaging--ROC analysis.
Nishiharu T; Yamashita Y; Abe Y; Mitsuzaki K; Tsuchigame T; Nakayama Y; Takahashi M
Radiology; 1999 Aug; 212(2):445-52. PubMed ID: 10429702
[TBL] [Abstract][Full Text] [Related]
4. CT and MR imaging of pancreatic cancer.
Ishiguchi T; Ota T; Naganawa S; Fukatsu H; Itoh S; Ishigaki T
Hepatogastroenterology; 2001; 48(40):923-7. PubMed ID: 11490841
[TBL] [Abstract][Full Text] [Related]
5. [Combined conventional magnetic resonance, magnetic resonance angiography, and magnetic resonance cholangiopancreatography in the diagnosis and staging of pancreatic carcinoma].
Catalano C; Pavone P; Laghi A; Scipioni A; Assael F; Fanelli F; Grossi A; Passariello R
Radiol Med; 1997 May; 93(5):556-60. PubMed ID: 9280938
[TBL] [Abstract][Full Text] [Related]
6. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer.
Koelblinger C; Ba-Ssalamah A; Goetzinger P; Puchner S; Weber M; Sahora K; Scharitzer M; Plank C; Schima W
Radiology; 2011 Jun; 259(3):757-66. PubMed ID: 21436084
[TBL] [Abstract][Full Text] [Related]
7. Secretin-stimulated multi-detector CT versus mangafodipir trisodium-enhanced MR imaging plus MRCP in characterization of non-metastatic solid pancreatic lesions.
Boraschi P; Donati F; Gigoni R; Salemi S; Faggioni L; Del Chiaro M; Boggi U; Bartolozzi C; Falaschi F
Dig Liver Dis; 2009 Nov; 41(11):829-37. PubMed ID: 19303825
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional linear endoscopic ultrasound-feasibility of a novel technique applied for the detection of vessel involvement of pancreatic masses.
Fritscher-Ravens A; Knoefel WT; Krause C; Swain CP; Brandt L; Patel K
Am J Gastroenterol; 2005 Jun; 100(6):1296-302. PubMed ID: 15929760
[TBL] [Abstract][Full Text] [Related]
9. MR-cholangiopancreaticography (MRCP) and MR-angiography: morphologic changes with magnetic resonance imaging.
Vahldiek G; Broemel T; Klapdor R
Anticancer Res; 1999; 19(4A):2451-8. PubMed ID: 10470174
[TBL] [Abstract][Full Text] [Related]
10. Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice.
Kishimoto S; Brender JR; Crooks DR; Matsumoto S; Seki T; Oshima N; Merkle H; Lin P; Reed G; Chen AP; Ardenkjaer-Larsen JH; Munasinghe J; Saito K; Yamamoto K; Choyke PL; Mitchell J; Lane AN; Fan TW; Linehan WM; Krishna MC
Elife; 2019 Aug; 8():. PubMed ID: 31408004
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based imaging of pancreatic malignancies.
Kinney T
Surg Clin North Am; 2010 Apr; 90(2):235-49. PubMed ID: 20362784
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic ultrasound in the diagnosis of pancreatic cancer.
Munroe CA; Fehmi SM; Savides TJ
Expert Opin Med Diagn; 2013 Jan; 7(1):25-35. PubMed ID: 23530842
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging.
Chirindel A; Alluri KC; Chaudhry MA; Wahl RL; Pawlik TM; Herman JM; Subramaniam RM
AJR Am J Roentgenol; 2015 May; 204(5):1093-9. PubMed ID: 25905947
[TBL] [Abstract][Full Text] [Related]
14. Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging.
Delrue L; Blanckaert P; Mertens D; Cesmeli E; Ceelen WP; Duyck P
J Comput Assist Tomogr; 2011; 35(4):434-8. PubMed ID: 21765297
[TBL] [Abstract][Full Text] [Related]
15. Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography.
Raman SP; Horton KM; Fishman EK
Cancer J; 2012; 18(6):511-22. PubMed ID: 23187837
[TBL] [Abstract][Full Text] [Related]
16. The role of endoscopic ultrasound in the diagnosis and staging of pancreatic adenocarcinoma.
Siddiqui AA; Tierney WM
J Okla State Med Assoc; 2005 Nov; 98(11):539-44. PubMed ID: 16379483
[TBL] [Abstract][Full Text] [Related]
17. Challenges of Pancreatic Cancer.
Dimastromatteo J; Houghton JL; Lewis JS; Kelly KA
Cancer J; 2015; 21(3):188-93. PubMed ID: 26049698
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and staging of pancreatic carcinoma: MRI versus multislice-CT -- a prospective study].
Grenacher L; Klauss M; Dukic L; Delorme S; Knaebel HP; Düx M; Kauczor HU; Büchler MW; Kauffmann GW; Richter GM
Rofo; 2004 Nov; 176(11):1624-33. PubMed ID: 15497081
[TBL] [Abstract][Full Text] [Related]
19. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.
Motosugi U; Ichikawa T; Morisaka H; Sou H; Muhi A; Kimura K; Sano K; Araki T
Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662
[TBL] [Abstract][Full Text] [Related]
20. MR imaging in the management of thoracic malignancies.
Templeton PA; Zerhouni EA
Radiol Clin North Am; 1989 Nov; 27(6):1099-111. PubMed ID: 2685876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]